Abbott Can't Kick Investor Suit Over Depakote Marketing
A federal judge on Wednesday refused to toss a shareholder derivative suit against Abbott Laboratories, finding the plaintiffs had adequately argued Abbott's directors knew the company was in trouble for marketing...To view the full article, register now.
Already a subscriber? Click here to view full article